Analyst Sees Amgen's (AMGN) Dmab Delay Opening a Buying Window
Tweet Send to a Friend
Leerink Swann maintains an 'Outperform' rating on Amgen (Nasdaq: AMGN).
Leerink analyst says, "This morning, AMGN announced it has received ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink analyst says, "This morning, AMGN announced it has received ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
